The Effect of Solifenacin on Cognitive Function following Stroke

The Effect of Solifenacin on Cognitive Function following Stroke

Background/Aims: Our aim was to investigate the effect of solifenacin (an anticholinergic) on cognitive function after stroke. Methods: We retrospectively reviewed 66 stroke cases who were prescribed solifenacin for more than 2 months. A control group was generated matching the patients both for sex...

Full description

Bibliographic Details
Main Author:	Jin-Woo Park
Format:	Article
Language:	English
Published:	Karger Publishers 2013-05-01
Series:	Dementia and Geriatric Cognitive Disorders Extra
Subjects:	Anticholinergics Solifenacin Stroke Cognitive symptoms Muscarinic receptors
Online Access:	http://www.karger.com/Article/FullText/350029

Similar Items

Clinical Factors Associated With Dose Escalation of Solifenacin for the Treatment of Overactive Bladder in Real Life Practice
by: Ji-Youn Chun, et al.
Published: (2014-03-01)

Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms
by: Kirill Vladimirovich Kosilov, et al.
Published: (2016-09-01)

Effectiveness of using Solifenacin compared to Mirabegron after double-J stent installation for treatment of lower urinary tract symptoms (LUTS)
by: Emmy Palinggi, et al.
Published: (2020-12-01)

COMPARISON OF SOLIFENACIN VERSUS COMBINATION OF SOLIFENACIN AND TAMSULOSIN IN IMPROVING UNILATERAL DOUBLE-J STENT RELATED LOWER URINARY TRACT SYMPTOMS - A PROSPECTIVE RANDOMIZED CONTROL TRIAL
by: Muhammad Tanveer Sajid, et al.
Published: (2021-02-01)

THE EFFECTIVENESS OF TAMSULOSIN, SOLIFENACIN, AND COMBINATIONS THERAPY TAMSULOSIN ADDED SOLIFENACIN ON LOWER URINARY TRACT SYMPTOMS AFTER DOUBLE J STENT INSERTION
by: Ida Bagus Putra Pramana, et al.
Published: (2019-07-01)

Overactive bladder symptoms recurrence after sudden versus gradual weaning of Solifenacin
by: Ahmed Abdelbary, et al.
Published: (2020-12-01)

Pooled solifenacin overactive bladder trial data: Creation, validation and analysis of an integrated database
by: Christopher R. Chapple, et al.
Published: (2016-12-01)

Solifenacin and Tolterodine are Equally Effective in the Treatment of Overactive Bladder Symptoms
by: Chen-Hsun Ho, et al.
Published: (2010-10-01)

Effect of two different doses of solifenacin succinate therapy (5mg, 10mg) for the treatment of ureteral stent (Double J) related symptoms in comparison to placebo
by: Ahmed Adil Mohammed, et al.
Published: (2020-06-01)

PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
by: N. A. Avxentyev, et al.
Published: (2016-09-01)

Solifenacin in overactive bladder syndrome: pharmacoeconomic analysis
by: Sergio Iannazzo, et al.
Published: (2008-03-01)

The efficacy of alpha-1A blocker (tamsulosin), antimuscarinic (solifenacin) and their combination in the management of double-J stent-related lower urinary tract symptoms: a randomized controlled study
by: Elsayed M. Salih, et al.
Published: (2021-02-01)

Improvement of the symptoms of lower urinary tract and sexual dysfunction with tadalafil and solifenacin after the treatment of benign prostatic hyperplasia with dutasteride
by: Kirill V. Kosilov, et al.
Published: (2020-06-01)

Central anticholinergic syndrome (CAS) in anesthesiology: a narrative review
by: Dmytro Dmytriiev, et al.
Published: (2019-06-01)

Efficacy and safety of solifenacin plus tamsulosin oral controlled absorption system in men with lower urinary tract symptoms: a meta-analysis
by: Ming-Chao Li, et al.
Published: (2015-02-01)

A rare case report of levofloxacin- and solifenacin-induced acute anaphylactic reaction in an elderly patient
by: Satish Eknath Bahekar, et al.
Published: (2019-01-01)

Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
by: Abdul Aziz MI, et al.
Published: (2018-10-01)

Effect of electroacupuncture versus solifenacin for moderate and severe overactive bladder: a multi-centre, randomized controlled trial study protocol
by: Qian Wen, et al.
Published: (2020-07-01)

Effects of Tamsulosin Combined With Solifenacin on Lower Urinary Tract Symptoms: Evidence From a Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials
by: Yuxuan Song, et al.
Published: (2020-05-01)

The relation between the storage symptoms before and after transurethral resection of the prostate, analysis of the risk factors and the prevention of the symptoms with solifenacin
by: Timucin Sipal, et al.

Efficacy of Additional Solifenacin Succinate Therapy for Storage Symptoms in Females with Uncomplicated Lower Urinary Tract Infection: The SOLUTION Randomized Controlled Trial
by: Harrina Erlianti Rahardjo, et al.
Published: (2018-10-01)

Pharmacoeconomics expediency of application of the combined preparation of Vezomni in comparison with a combination of Tamsulosin and Solifenacin in the form of monopreparations
by: S. K. Zyryanov, et al.
Published: (2018-06-01)

Influence of solifenacin on the improvement of storage symptoms in the early period after photoselective vaporization of the prostate
by: Su Jin Kim, et al.
Published: (2019-11-01)

Effectiveness and durability of solifenacin versus percutaneous tibial nerve stimulation versus their combination for the treatment of women with overactive bladder syndrome: a randomized controlled study with a follow-up of ten months
by: Carlo Vecchioli-Scaldazza, et al.

Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder
by: Yankai Xu, et al.
Published: (2017-09-01)

The Efficacy of Solifenacin Added to Α-Adrenergic Antagonists in the Treatment of Lower Urinary Tract Symptoms in Males with Benign Prostate Hyperplasia (The Iraqi Experience)
by: Nibbras I. AL-Hamdani, et al.
Published: (2015-07-01)

Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin – A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case–Control Study
by: Allameh F, et al.
Published: (2020-06-01)

THE EFFICACY COMPARISON OF MIRABEGRON AS A MONOTHERAPY VERSUS ITS COMBINATION WITH SOLIFENACIN IN OVERACTIVE BLADDER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
by: Hasan Madani, et al.
Published: (2021-07-01)

Solifenacin/Mirabegron Induces an Acute Compliance Increase in the Filling Phase of the Capacity-Reduced Urinary Bladder: A Pressure-Volume Analysis in Rats
by: Hsien-Yu Peng, et al.
Published: (2021-05-01)

Fixed and separate combination of solifenacin and tamsulosin in urinary disorders associated with benign prostatic hyperplasia: a choice based on price and value comparison
by: A. G. Tolkushin, et al.
Published: (2019-08-01)

Influence of the Short-term Intake of High Doses of Solifenacin and Trospium on Cognitive Function and Health-Related Quality of Life in Older Women With Urinary Incontinence
by: Kirill Kosilov, et al.
Published: (2018-03-01)

Reversal of MK-801-Induced Disruptions in Social Interactions and Working Memory with Simultaneous Administration of LY487379 and VU152100 in Mice
by: Paulina Cieślik, et al.
Published: (2019-06-01)

Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study
by: Hoon Choi, et al.
Published: (2018-03-01)

COMPARISON OF EFFICACY AND TOLERABILITY OF TWO SELECTIVE M3 RECEPTOR ANTAGONISTS SOLIFENACIN AND DARIFENACIN IN WOMEN WITH OVERACTIVE BLADDER – THE SOLIDAR STUDY
by: Igor But, et al.
Published: (2018-02-01)

Tiotropium bromide inhibits human monocyte chemotaxis
by: Kurai M, et al.
Published: (2012-08-01)

Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II
by: Carlota M. Grossi, et al.
Published: (2020-07-01)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
by: Tashkin DP, et al.
Published: (2018-06-01)

Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial
by: Shin YS, et al.
Published: (2016-09-01)

Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease
by: Bateman Eric D, et al.
Published: (2011-04-01)

Prophylactic Anticholinergic Medications to Prevent Drug-Induced Extrapyramidal Symptoms: A Systematic Review
by: Dare, Reese
Published: (2017)